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A B S T R A K  
Pemberian imunisasi dasar dengan vaksin DPT 3 kali masih mengalami beberapa hambatan operasi- 
onal terutama d i  daerah pedesaan di Indonesia. 
Tujuan dari penelitian ini adalah untuk mengetahui apakah pemberian imunisasi dasar dengan 
vaksin DPT 2 kali telah cukup memberikan kekebalan pada bayi terhadap penyakit pertussis. 
Bayi sebanyak 1152 orang berumur antara 3-8 bulan yang di pilih secara acak dari 2 Kecamatan 
di Kabupaten ,/ombang, Jawa Timur dibagi menjadi 3 group. 
Group I menerima vaksinasi DPT 2 kali dengan jarak waktu 6 minggu (DPT-DPT-DT), group I/ me 
nerima vaksinasi DPT 2 kall dengan jarak waktu 3 bulan (DPT-DT- DPT) dan group III menenma vak- 
sinasi DPT 1 kali (DPT-DT- DT) 
Hasil yang diperoleh menunjukkan bahwa kekebalan terhadap pertussis yang didapat dari vaksi- 
nasi DPT 2 kali dengan jarak waktu 3 bulan lebih baik bila dibandingkan dengan hasil vaksinasi DPT 
2 kali dengan jarak waktu 6 minggu. Walaupun demikian "efficacy" vaksin tersebut masih perlu dimo- 
nitor terus pada anakyang sama selama 2 tahun lagi sebelum dapat diterapkan. 
INTRODUCTION 
The expanded Programme on Immunization 
in Indonesia at present consists of BCG and 
DPT (diphtheria, pertussis, tetanus) polio and 
measles vaccination. In the trivalent DPT vaccine, 
the pertussis component is the most labile one 
towards storage temperature (cold chain). 
The standard prosecedure to immunize infant 
against pertussis is to give three times injection 
to vaccinees at a monthly interval. This proce- 
dure has never been carried out completely 
in rural areas in Indonesia because of many 
reasons, so that the protection of infants 
against pertussis has not been attained. 
Reduction in the number of injections is 
considered important for a feasible but yet 
effective immunization programme. IJence 
it is of interest to investigate the possibility 
to  reduce the number of injections by chang- 
ing the method of immunization, i.e. the in- 
terval between the injections. 
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According to  the results of many field trials 
on DPT vaccination, the interval between the 
first ahd the second injection plays an important 
role in developing a high titre of agglutinin as 
indicator of antibody against pertussis. Diph- 
theria and tetanus antitoxin titres reached 
protective levels in about 90% of both antigen 
groups after two doses (8 ,2 ,7 ) .  
The objective of this study was to see whe- 
ther two injections of DPT vaccine are enough 
for basic immunization in Indonesia. This study 
will be followed by monitoring the reduction 
in the incidence of pertussis among the vacci- 
nated groups, which might be correlated with 
the antibody level. 
MATERIALS AND METHODS 
A total of 1152 infants between 3 - 8 months 
of age were selected randomly from 19 villages 
of Kecamatan (District) Mojoagung and Sumo- 
bit0 in Kabupaten Jombang, East Java, which 
cover an area with a total population of 100,400 
people and are served by two Health Centres. 
The study was conducted double blind. The 
infants under study were randomly divided into 
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3 groups of 380 - 390 infants. 
Group I received two consecutive shots of 
DPT vaccine, and one shot of adsorbed DT toxo- 
id, each 0,5 rnl (DPT-DPT-DT). 
Group I1 received one shot of DPT vaccine, 
one shot of adsorbed DT toxoid, and one shot of 
DPT vaccine, each 0.5 ml (DPT-DT-DPT). 
Group 111 received two consecutive shots of 
DT adsorbed toxoid, and one shot of DPT vac- 
cine, each 0.5 ml (DT-DT-DPT). 
Vaccines were given subcutaneously at a six- 
weekly interval. Adsorbed DT toxoid was used 
as placebo. Before the first injection and six 
weeks after the third injection. blood was collec- 
ted from each infant. A total of 931 blood 
samples were collected. 
All immunized children were visited 48 hours 
later by a local village workers, who inquired the 
parents after side-effects. 
Vaccine: The DPT vaccine used in the trial 
was prepared by Biofarma, Bandung, Indonesia. 
The pertussis component contained 16 Opacity 
Units (OU) of Bordetella pertussis cells per dose. 
The DPT vaccine batch No. 79167A was selected 
among 12 batches of vaccine prepared for this 
purpose. The potency of the vaccine was 10.98 
IU/ml, as measured by the active mouse pro- 
tection test, and toxicity was passed by the 
mouse weight gain test. During the field trial 
vaccines were kept at  4 ' ~ .  Vaccine samples were 
collected from the field and tested in their po- 
tency of the pertussis component. 
Blood coll~ction: Finger blood samples of 
infants were collected by heparinized capillary 
pipettes and then mixed with 0.2 ml phospate 
buffer saline in a vinyl tube of 2 ml. The sepa- 
rated sera were stored for a few days at -20°C at  
the local Health Centre and sent henceforth to  
Jakarta for titration. 
Antibody titration: Antibody against B. per- 
tussis was determined by the agglutination test, 
using the microtechnique. An antigen was pre- 
pared from B. pertussis strain 18 - 323, prepared 
by the Laboratory of Biological Standardization, 
Biomedical Research Centre in Jakarta. The qua- 
lity of the antigen was also checked by The Na- 
tional Institute of Health, Tokyo, Japan. The 
entigen contained 10 X lo9 organisms/ml. All 
agglutination tests were performed with the same 
batch of antigen. Two-fold dilutions of each 
serum were made. An equal volume of antigen 
(0.05 ml) and diluted serum (initial dilution was 
1 : 5) were thoroughly mixed. The end point 
titre was determined after 2 hours incubation at 
3 7 ' ~ ,  followed by overnight incubation at 4 ' ~ .  
An anti B. pertussis rabbit serum, prepared with 
a stable 1 ,  2,  (3) Tohama strain received frorn 
The National Institute of Health, Tokyo, Japan, 
was used as a positive control. Agglutinin titres 
of less than 1 : 10 were considered "negative". 
RESULT 
Table 1 shows the coverage of immunization 
of each study group. As listed in the last column 
the mean coverage was 84.1%. There was no 
significant difference in the coverage among the 
3 groups of infants. 
It was due to h special effort, with a good co- 
ordination between the local community leaders 
and the local health personnel, that effective 
information could be given to parents about the 
purpose of the study. 
There was no decrement of the potency of 
pertussis vaccines collected from the field. 
Table 1. .The coverage of immunization 
Number of Number of Coverage of 
selected having re- immuniza- 
infants ceived 3 x tion 
injections ( % ) 
I (DPT-DPT-DT) 381 31 4 82.41 
I I  (DPT-DT-DPT) 390 332 85.1 3 
I l l  (DT-DT-DPT) 381 325 84.77 
Total Number 11 52 969 M = 84.1 
................................. 
The distribution of the agglutinin titres of 
the infants in each group before and after immu- 
nization is shown in Table 2. 
The percentage. of infants, who had pertussis 
agglutinin titres higher than 1 : 10 before immu- 
nization was 1 1.9% in group I ,  15 .O% in group 11, 
and 12.8% in group 111. 
Table 3 shows the distribution of agglutinin 
titres after immunization of sero-negative infants. 
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Table 2. Distribution of agglutinin titre of 
infants before immunization 
................................. 
GROUP I GROUP 1 1  GROUP Ill 
N =305 N =313 N =313 
Agglutinin 
titre * 
Number of Number of 
sera sera 
Number of 
sera 
Infants with 
positive t i tre 11.9% 15.01% 12.8% 
................................. 
* Reciprocal values of serum dilutions. 
The mean titre in group I ,  11,111 was respectively 
34.7 (30.3 - 39.8), 115.2 ( 9 6 5  - 137.6) and 
9.8 (8.9 - 10.8). Group I1 shows a higher per- 
centage of infants with higher titre levels. 
Table 3. Distribution of agglutinin titre after 
immunization of sero negative infants. 
................................. 
GROUP I GROUP l l  GROUP Ill 
N = 269 N = 266 N = 273 
Titre o f  (DPT-DPT- (DPT-DT- (DT-DT- 
agglutinin"* DT) DPT) DPT) 
Number of Number o f  Number of 
sera sera sera 
................................. 
Mean titre * *  34.7 11 5.2 9.8 
(30.3-39.8:) (96.5~1.3T.6*1 :(8.9-10.8") 
*. Fiducial l imit at p = 0.95. 
*' Reciprocal values of serum dilutions. 
The sero-conversion rates at different titres 
levels in the three groups is shown in Table 4. 
There was a significant difference in the sero- 
conversion rate between group I ar.d group 11. 
It seems that the difference was due to the diffe- 
rence in the time-interval of immunization. In 
group 111 the sero-conversion rates at different 
titre levels were very low due to the only one 
shot of DPT vaccine. 
Table 4. Sero conversion rate at different 
titre levels in the 3 groups. 
................................. 
GROUP I GROUP ll GROUP Ill 
Agglutinin (DPT-DPT- DPT-DT- (DT-DT- 
titre DT) DPT) DPT) 
N = 269 N = 266 N = 273 
( % )  ( % I  ( % )  
................................. 
* Reciprocal values of serum dilutions. 
Active surveillance in the study area did not 
record an outbreak of pertussis during the trial 
period. Hence it can be concluded that the in- 
crease of agglutinin titres in group I and group 
I1 can be regarded as a result of the vaccination. 
No major side-effects (convulsions or neurolo- 
gical symptoms) were recorded. Redness after 
DPT injection was recorded in 17.4 to 39.2% 
of the children compared to 8.7 to 29 percent 
after DT injection. Rise of temperature, which 
was based on informations given by the mothers, 
was recorded in 52.5 to 63,8% of the children 
after DPT injection, compared to 32.6 to 42.7% 
after DT injection. 
These numbers are however not fully reliable, 
since the inquiry about temperature was conduc- 
ted by village workers without medical verifica- 
tion. 
DISCUSSION 
The present study shows that a majority of 
infants at the age of 3 - 8 months in the study 
area did not have immunity against pertussis 
and were exposed to a high risk of infection be- 
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fore vaccination. A small proportion of infants 
(11%) already had detectable antibodies. This 
may be due to the maternal antibodies 01. natural 
infection with pertussis bacilli. 
Sako assumed that an agglutinin response of 
1 : 320 is an indicator of clinical immunity 
against pertussis infection (9), but immunity may 
exist in the absence of demonstrable agglutinins 
' (Miller, 6). 
When the agglutinin titres of 1 : 80 and more 
were taken, the pertussis conversion rate was 
31.6, 69.2, 5.1 in group I, 11, 111 respectively. 
This study indicates that the interval of 3 
months has given better result than the interval 
of 6 weeks. 
In this respect Wilkins et  al. (1 1) showed, that 
when the titres of 1 : 8 0  were taken, 69% out of 
88 infants exceeded the level by 2 injections 
with an interval of 60 days. Moreover, a field 
trial in the Philippines, with 2 injections of DPT 
vaccine containing pertussis bacilli of 10 and 16 
IOU per Jose given at  a 6 months' interval, 
showed that 28% out of 97  infants and 91% out 
of 104 infants, respectively had an agglutinin 
titre of 1 : 320 or more (2). Furthermore, An- 
dreescu et al (1) showed that 2 injections of DPT 
vaccine containing 20 IOU per dose given at a 
monthly interval can induce an agglutinin titre 
of 1 : 320 or more in 50% of the samples. 
solid immunity in infants. The vaccination me- I 
thod against pertussis with 2 injections with a 
3 month interval may be more practical in Indo- 
nesia in view of the operational feasibility. The , 
programme is actually shifting to the schedule 
of 3 DPT vaccine injections with the introduc- 
tion of polio immunization. 
The study area will be further kept under ac- 
tive surveillance to monitor the actual protection 
of the group against natural infection. 
CONCLUSION 
Another clinical study for 2 years might be 
needed to look at the efficacy of the vaccine, 
before an immunization method could be adop- 
ted in the Expanded Programme of Immunisa- 
tion in Indonesia. 
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